Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

HB PHARMA FRANCE : revenue, balance sheet and financial ratios

HB PHARMA FRANCE is a French company founded 8 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in MULHOUSE (68200), this company of category PME shows in 2019 a net income negative of -4 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - HB PHARMA FRANCE (SIREN 839347853)
Indicator 2022 2020 2019
Revenue N/C N/C N/C
Net income 0 € 0 € -4 200 €
EBITDA N/C N/C -4 200 €
Net margin N/C N/C N/C

Revenue and income statement

In 2022, HB PHARMA FRANCE records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -320%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-320.0%

Solvency indicators evolution
HB PHARMA FRANCE

Sector positioning

Debt ratio
0.0 2022
2019
2020
2022
Q1: 0.0
Med: 6.23
Q3: 53.97
Excellent

In 2022, the debt ratio of HB PHARMA FRANCE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-320.0% 2022
2019
2020
2022
Q1: 15.33%
Med: 37.18%
Q3: 59.34%
Watch

In 2022, the financial autonomy of HB PHARMA FRANCE (-320.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
0.0 years 2019
2019
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Excellent

In 2019, the repayment capacity of HB PHARMA FRANCE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 23.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

23.81

Liquidity indicators evolution
HB PHARMA FRANCE

Sector positioning

Liquidity ratio
23.81 2022
2019
2020
2022
Q1: 136.77
Med: 203.41
Q3: 332.18
Watch

In 2022, the liquidity ratio of HB PHARMA FRANCE (23.81) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
0.0x 2019
2019
Q1: 0.0x
Med: 0.14x
Q3: 4.04x
Average

In 2019, the interest coverage of HB PHARMA FRANCE (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
HB PHARMA FRANCE

Positioning of HB PHARMA FRANCE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare HB PHARMA FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about HB PHARMA FRANCE

What is the revenue of HB PHARMA FRANCE ?

The revenue of HB PHARMA FRANCE is not publicly disclosed (confidential accounts filed with INPI).

Is HB PHARMA FRANCE profitable?

HB PHARMA FRANCE recorded a net loss in 2019.

Where is the headquarters of HB PHARMA FRANCE ?

The headquarters of HB PHARMA FRANCE is located in MULHOUSE (68200), in the department Haut-Rhin.

Where to find the tax return of HB PHARMA FRANCE ?

The tax return of HB PHARMA FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does HB PHARMA FRANCE operate?

HB PHARMA FRANCE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.